| Literature DB >> 34248272 |
Georges E Daoud1, Dante L Pezzutti1, Calvin J Dolatowski2, Ricardo L Carrau1,3,4, Mary Pancake2, Edward Herderick2, Kyle K VanKoevering1,3,4.
Abstract
Additive manufacturing, or 3-Dimensional (3-D) Printing, is built with technology that utilizes layering techniques to build 3-D structures. Today, its use in medicine includes tissue and organ engineering, creation of prosthetics, the manufacturing of anatomical models for preoperative planning, education with high-fidelity simulations, and the production of surgical guides. Traditionally, these 3-D prints have been manufactured by commercial vendors. However, there are various limitations in the adaptability of these vendors to program-specific needs. Therefore, the implementation of a point-of-care in-house 3-D modeling and printing workflow that allows for customization of 3-D model production is desired. In this manuscript, we detail the process of additive manufacturing within the scope of medicine, focusing on the individual components to create a centralized in-house point-of-care manufacturing workflow. Finally, we highlight a myriad of clinical examples to demonstrate the impact that additive manufacturing brings to the field of medicine.Entities:
Keywords: 3-D printing; Additive manufacturing; Biomaterial; Biomedical; Lithography (deposition); Polymer
Year: 2021 PMID: 34248272 PMCID: PMC8259775 DOI: 10.1557/s43578-021-00270-x
Source DB: PubMed Journal: J Mater Res ISSN: 0884-1616 Impact factor: 3.089
Figure 1(a) Identify an institution that has the case volume and proper imaging equipment to support a self-sufficient 3-D printing lab; (b) Recruit a lead physician (surgeon, radiologist, etc.) to champion 3-D printing efforts; (c) Utilize tumor board, trauma cases, and other clinical scenarios that identify a wide range of patients who could benefit from 3-D models; (d) Ensure proper cross-sectional imaging (CT/MRI) Digital Imaging and Communications in Medicine (DICOM) access; (e) Ensure DICOM storage for selected patients remaining under the institution’s HIPAA-protected firewall; (f) Engineering team manipulates each patient’s specific imaging and creates 3-D Computer-Aided Design (CAD); (g) Final CAD model print execution per clinical requirements; (h) Quality control for proper sterilization and model preparation for clinical use in the operating room; (i) Feedback loop between Quality Control & Inspection and Segmentation and Creation of Models to improve future prints; (j) Deliver the model for clinical application per institutional requirements; and (k) Feedback loop between Clinical Application and 3-D Printing to improve future prints.
The various 3-D printing techniques and a description of each process is detailed.
| Various characteristics of 3-D printing | ||||
|---|---|---|---|---|
| Printing technique | Process description | Materials | Biomedical applications | Printer examples |
| Extrusion-Based Printing: (1) 1FDM; (2) Bioprinting | (1) Object is created through the layering of a melted thermoplastic material; (2) A nozzle is used to lay down biologic materials until scaffold is built [ | (1) ABS2, PLA3, nylon; (2) Alginate, gelatin, collagen, fibrin | (1) Produces anatomical models (both rigid and soft) for surgical planning and preparation; (2) Used in the bioprinting of tissues, organs and cell culture scaffolds | (1) |
| Material Sintering (Powder-Based Printing): (1) 4SLS; (2) 5EBM | (1) Powdered materials are fused together by a high-power laser beam in a layer-by-layer pattern [ | (1) Nylon, polyamide; (2) cobalt-chrome alloy, titanium | (1 & 2) Craniofacial and orthopedic metallic implants, temporary rigid implants | |
| Material Sintering (Vat Polymerization-Based Printing): (1) 6SLA; (2) 7CLIP | (1) Photo-polymer resin is selectively hardened in layers using a UV laser beam; (2) Same as SLA, except UV beam travels from bottom of resin through transparent window and build platform raises object [ | (1 &2) Photopolymers | (1 & 2) Used for printing of both soft and hard tissues for surgical planning, microneedle production | (1) Form 3 |
| Droplet-Based Printing: (1) Binder Jetting/Inkjet; (2) Polyjet | (1) Liquid-based binding material layered onto powder bed in an alternating fashion until object is completely formed [ | (1) Starch & gypsum serve as powder beds, water, phosphoric acid, citric acid, 8PDLLA function as binding agent; (2) polystyrene, polycarbonate, polypropylene | (1 & 2) Various scaffolds dedicated to cell culturing as well as soft tissue and organ development47 | (1) |
Furthermore, the most used materials and biomedical applications for each technique are indicated. Finally, a non-comprehensive list of example 3-D printers on the market are correlated with each 3-D printing technique.
FDM: Fusion Deposition Modeling; ABS: acrylonitrile butadiene styrene; PLA: polylactic acid; SLS: Selective Laser Sintering; EBM: Electron Beam Manufacturing; SLA: Stereolithography; Continuous Liquid Interface Production; PDLLA: poly-DL-lactide.
Figure 2(a–c) Computed Tomography (CT) scan imported and isolated using Materialize 3-matic; (d) Cropped 3-D mandible model in Materialize 3-matic; (e) Final mandible in PreForm prior to printing; (f) Printed final mandible with post-processing complete; (g) Autoclaved sterilized mandible model being used intraoperatively for reconstructive surgery.
The most common 3-D printing techniques with cost ranges of their associated printers, materials, and software are detailed.
| 1FDM | Bioprinting | 2EBM | 3SLS | 4SLA | 5PJP | |
|---|---|---|---|---|---|---|
| Associated Costs | ||||||
| Printer Cost Range | $200-$6,000 | $10,000-$200,000 | $100,000-$1,000,000 | $5,000-$200,000 | $3,500-$80,000 | $20,000-$100,000 |
| Materials Cost Range | $15-$600 per kg | $40-$1,000 per 20 mL | $80-$600 per kg | $45-$100 per kg | $40-$500 per liter | $100-$1000 per liter |
| 6Software & Their Costs | Meshmixer | |||||
1FDM: Fusion Deposition Modeling; 2EBM: Electron Beam Manufacturing; 3SLS: Selective Laser Sintering; 4SLA: Stereolithography; 5PolyJet Printing; 6Compatibility between software and 3-D printer can vary.
Figure 3(a) MRI showing unclear evidence of airway obstruction in a fetus with known congenital malformation of the maxillofacial area; (b) Final 3-D-printed model that demonstrates an isolated upper lip soft tissue mass not involving the airway of the fetus; (c) Patient delivered successfully via cesarean section without need for emergency ex utero intrapartum treatment (EXIT) procedure given 3-D model demonstration of clear airway.
Figure 4(a) 3-D-printed model of the patient’s temporal bone depicting various deformities; (b) Deformities are shown in pink with proposed tegmen plate reconstruction overlaying the defects in blue; (c) Tegmen plate reconstruction overlaying the deformity; (d) Tegmen plate matching the specific patient anatomy.
Figure 5(a) 3-D-printed split VentMI ventilation model; (b) Complete set of VentMI split ventilation pieces ready for clinical use.